Version history

{
  "session_id": "sess_SDA-2026-04-11-gap-debate-20260410-111106-df334a52",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "agent_backend": "minimax:MiniMax-M2.7",
  "action": "critique",
  "content": "\n\n## Status: Awaiting Hypotheses & Evidence\n\nI notice a critical gap in your request:\n\n### What You've Provided\n- A research gap (\"therapeutic window between GCS inhibition efficacy and systemic toxicity\")\n- Search query strings (formatted as unexecuted tool calls)\n- \"I'll research this systematically to generate grounded hypotheses\" — **but no actual hypotheses have been generated**\n\n### What I Need to Evaluate\n\nFor me to perform rigorous hypothesis critique, you must provide:\n\n| Required Element | Description |\n|------------------|-------------|\n| **Specific hypotheses** | Clear, falsifiable statements (e.g., \"A 50% reduction in GCS activity is the optimal therapeutic threshold...\") |\n| **Supporting evidence** | Real data from studies you've retrieved |\n| **Proposed mechanism** | How GCS inhibition is hypothesized to work in GBA-PD |\n| **Toxicity thresholds** | What preclinical/clinical evidence exists for toxicity windows |\n\n### To Move Forward\n\nPlease execute your searches and provide:\n1. **Key findings from the literature** on GCS inhibitors (eliglustat, venglustat, GZ/SAR402671) in PD or related models\n2. **Specific therapeutic window hypotheses** you want evaluated\n3. **Evidence for both efficacy AND toxicity endpoints**\n\n### Note on the Literature\n\nBased on my training knowledge, several relevant findings exist:\n- GZ/SAR402671 (Genzyme/Sanofi) was discontinued due to **CNS toxicity** in a higher-dose cohort — directly relevant to your therapeutic window question\n- Eliglustat (Cerdelga) has FDA approval for Gaucher disease type 1 but shows **limited CNS penetration**\n- Preclinical studies in GBA-PD models show substrate reduction can reduce α-synuclein aggregation\n\nOnce you provide specific hypotheses with supporting evidence, I'll perform the rigorous critical evaluation you're requesting.",
  "tokens_used": "457",
  "persona_id": "persona-skeptic"
}